Current location:Home > Pharmaceutical
Product
(4R,6R,7E,10Z)-2,3,3aβ,4,5,6,9,11aα-Octahydro-3-methylene-6-hydroxy-2,9-dioxo-4-(2-methylpropanoyloxy)-6,10-dimethylcyclodeca[b]furan
- CAS No.: 59979-56-5
- Purity: 99%
Manufacturers supply cost-effective and customizable (4R,6R,7E,10Z)-2,3,3aβ,4,5,6,9,11aα-Octahydro-3-methylene-6-hydroxy-2,9-dioxo-4-(2-methylpropanoyloxy)-6,10-dimethylcyclodeca[b]furan 59979-56-5
- Molecular Formula: C19H24O6
- Molecular Weight: 348.396
- Vapor Pressure: 1.8E-13mmHg at 25°C
- Boiling Point: 530.5°Cat760mmHg
- Flash Point: 186.9°C
- PSA: 89.90000
- Density: 1.2g/cm3
- LogP: 1.87830
(4R,6R,7E,10Z)-2,3,3aβ,4,5,6,9,11aα-Octahydro-3-methylene-6-hydroxy-2,9-dioxo-4-(2-methylpropanoyloxy)-6,10-dimethylcyclodeca[b]furan(Cas 59979-56-5) Usage
|
General Description |
The chemical compound "(4R,6R,7E,10Z)-2,3,3aβ,4,5,6,9,11aα-Octahydro-3-methylene-6-hydroxy-2,9-dioxo-4-(2-methylpropanoyloxy)-6,10-dimethylcyclodeca[b]furan" is a complex molecule with a cyclodeca[b]furan ring structure. It contains a 3-methylene group, a 6-hydroxy group, and a 2,9-dioxo functional group. It also has a 2-methylpropanoyloxy substitution. The stereochemistry of the compound includes four chiral centers at the 4, 6, 7, and 11a positions, which are designated as (4R,6R,7E,10Z). (4R,6R,7E,10Z)-2,3,3aβ,4,5,6,9,11aα-Octahydro-3-methylene-6-hydroxy-2,9-dioxo-4-(2-methylpropanoyloxy)-6,10-dimethylcyclodeca[b]furan likely has a range of potential pharmaceutical applications due to its unique structure and functional groups, but further research would be needed to determine its specific properties and potential uses. |
InChI:InChI=1/C19H24O6/c1-10(2)17(21)25-15-9-19(5,23)7-6-13(20)11(3)8-14-16(15)12(4)18(22)24-14/h6-8,10,14-16,23H,4,9H2,1-3,5H3/b7-6-,11-8-/t14-,15-,16+,19+/m1/s1
59979-56-5 Relevant articles
Stereochemistry of Ciliarin, Zexbrevin, and Their Relatives
Chowdhury, Pratish K.,Sharma, Ram P.,Thyagarajan, Gopalakrishna,Herz, Werner,Govindan, Serengolam V.
, p. 4993 - 4997 (2007/10/02)
-
59979-56-5 Process route
-
-
34367-14-1
orizabin
-
-
59979-56-5
tagitinin-C
| Conditions | Yield |
|---|---|
|
With
sodium acetate; acetic anhydride;
at 100 ℃;
for 0.5h;
|
70%
|
-
-
75197-73-8,75247-16-4
Isobutyric acid (Z)-(1R,2R,4R,11R)-4-hydroxy-4,9-dimethyl-14-methylene-8,13-dioxo-6,12-dioxa-tricyclo[9.3.0.05,7 ]tetradec-9-en-2-yl ester
-
-
59979-56-5
tagitinin-C
| Conditions | Yield |
|---|---|
|
Multi-step reaction
with
2
steps
1: aq. AcOH, Zn / 1 h / 100 °C
2: 70 percent / sodium acetate, acetic anhydride / 0.5 h / 100 °C
With
sodium acetate; acetic anhydride; acetic acid; zinc;
|
59979-56-5 Upstream products
-
34367-14-1
orizabin
-
75197-73-8
Isobutyric acid (Z)-(1R,2R,4R,11R)-4-hydroxy-4,9-dimethyl-14-methylene-8,13-dioxo-6,12-dioxa-tricyclo[9.3.0.05,7 ]tetradec-9-en-2-yl ester
59979-56-5 Downstream products
-
59979-58-7
tagitinin E
-
59979-57-6
tagitinin F